002422 Sichuan Kelun Pharmaceutical
- 32.66
- +1.61+5.19%
Sichuan Kelun Pharmaceutical News
Colon Pharmaceuticals: Investor Relations Activity Record Form for October 29, 2024
Colon Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Directors
Colon Pharmaceuticals: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Supervisors
Colon Pharmaceuticals: Verification Opinions on Using Some Idle Funds Raised to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Deliberation Opinions at the Fourth Special Meeting of Independent Directors in 2024
Colon Pharmaceuticals: Announcement on Using Some Idle Funds Raised to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Announcement of Resolutions of the Third Meeting of the Eighth Board of Supervisors
Colon Pharmaceuticals: Announcement on the use of letters of credit and own foreign exchange to pay for fund-raising project funds and replace them in equal amounts with the raised funds
Colon Pharmaceuticals: Announcement on the use of bank acceptance notes to pay funds for fund-raising projects and replace them in equal amounts with raised funds
Colon Pharmaceutical: Announcement of Resolutions of the Third Meeting of the Eighth Board of Directors
Colon Pharmaceuticals: Verification Opinions on Using Bank Acceptance Notes, Letters of Credit, and Own Foreign Exchange to Pay for Fund-raising Project Funds and Replace the Raised Funds in Equal Amounts
Colon Pharmaceuticals: Investor Relations Activity Record Form for August 29, 2024
Colon Pharmaceutical: “Constitution of Sichuan Colon Pharmaceutical Co., Ltd.” (August 2024)
Colon Pharmaceuticals: Debt Financing Management System (August 2024)
Colon Pharmaceuticals: Announcement on changing the use of some funds raised
Colon Pharmaceutical: Inspection Opinions of Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the change in the use of some funds raised by Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceuticals: Semi-Annual Report Board Resolution Announcement
Colon Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Colon Pharmaceuticals: Special Report on the Storage and Actual Use of Funds Raised for the 2024 Semi-Annual Year
Sichuan Kelun Pharmaceutical: Announcement of the results of the first phase of asset-backed debt financing instruments (Science and Technology Bill) issued in 2024.
Analysis
Price Target
No Data
No Data